Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Immune digital twins for complex human pathologies: applications, limitations, and challenges

  • Niarakis, Anna
  • Montagud, Arnau
  • Valencia, Alfonso
Niarakis, Anna et al., Digital twins represent a key technology for precision health. Medical digital twins consist of computational models that represent the health state of individual patients over time, enabling optimal therapeutics and forecasting patient prognosis. Many health conditions involve the immune system, so it is crucial to include its key features when designing medical digital twins. The immune response is complex and varies across diseases and patients, and its modelling requires the collective expertise of the clinical, immunology, and computational modelling communities. This review outlines the initial progress on immune digital twins and the various initiatives to facilitate communication between interdisciplinary communities. We also outline the crucial aspects of an immune digital twin design and the prerequisites for its implementation in the clinic. We propose some initial use cases that could serve as "proof of concept" regarding the utility of immune digital technology, focusing on diseases with a very different immune response across spatial and temporal scales (minutes, days, months, years). Lastly, we discuss the use of digital twins in drug discovery and point out emerging challenges that the scientific community needs to collectively overcome to make immune digital twins a reality., This work is based on work during the three-week workshop on Building Immune Digital Twins, which was made possible by the support of the Institut Pascal, University of Paris-Saclay, France, via the program Investissements d’avenir, ANR-11-IDEX-0003-0. We would also like to thank Genopole for supporting the workshop. The authors also acknowledge the following support: AN was supported by a public-private partnership grant (CIFRE contract, no. 2020/0766) with SANOFI-AVENTIS R&D. R.L. acknowledges financial support from the Defense Advanced Research Projects Agency (grant HR00112220038), and the National Institutes of Health (grants R01 GM127909, R01 AI135128, and R01 HL169974). L.C.M., B.S., and L.G. acknowledge support from the European Commission (grants H2020-SC1-BHC-11-2020 963845 and Digital Europe EDITH-CSA 101083771). M.L.B. acknowledges support from the National Institutes of Health (grants R24 GM137787 and P41 EB023912). L.L.F. acknowledges financial support from the Defense Advanced Research Projects Agency (grant HR00112220038). L.H. acknowledged support from NIH/NCI Transition Career Development Award to Promote Diversity (K22-CA237857). L.S.V. acknowledges support from the National Institutes of Health (grants R01 AI135128, R01 HL169974, K25 AI175668). P.H. acknowledges support from the Prime Ministers’ Research Fellowship (PMRF). H.B. acknowledges the support of ZonMw (Grant No. 10430012010015) N.N. acknowledges support from the Knowledge Foundation (20200017) and The Swedish Fund for Research Without Animal Experiments. A.M., J.C.C., and A.V. acknowledge support from the European Commission (grants CREXDATA 101092749, PerMedCoE 951773, and EDITH-CSA 101083771). F.M. acknowledges support from the Italian Ministry of Health (grant “Ricerca Corrente” Linea 4 Project 5 and “5 per 1000–2021” Grant No. 5M-2021-23683787) and the European Commission with HORIZON programme (Grant No. 101046203—BY-COVID). J.A.G. acknowledges support from the National Institutes of Health (grants U24 EB028887) and the National Science Foundation (grants NSF 2303695, NSF 2120200, and NSF 1720625). G.A. and C.C. acknowledge support from the National Institutes of Health Award UO1EB025825 and the Defense Advanced Research Projects Agency through Cooperative Agreement D20AC00002 awarded by the U.S. Department of the Interior (DOI), Interior Business Center. K.R. was supported by the BMBF (Federal Ministry of Education and Research) in DAAD project 57616814 (SECAI, School of Embedded and Composite AI) as part of the program Konrad Zuse Schools of Excellence in Artificial Intelligence. Further, KR was supported by the imSAVAR and the CERTAINTY project. imSAVAR received funding from the Innovative Medicine Initiative 2 Joint Undertaking (JU) under grant agreement No 853988. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and JDRF INTERNATIONAL. The CERTAINTY project is funded by the European Union (Grant Agreement 101136379)., Peer reviewed